Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres-Reference-Cited by-同舟云学术

Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres

Published:2018-10-03 Issue:1 Volume:42 Page:35-43
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Kant Agnes^ORCID,de Vries Loes,Rolfes Leàn

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/article/10.1007/s40264-018-0729-0/fulltext.html

Reference23 articles.

1. Mitchell AA. Systematic identification of drugs that cause birth defects–a new opportunity. N Engl J Med. 2003;349(26):2556–9.

2. World Health Organization. The importance of pharmacovigilance: safety monotoring of medicinal products. 2002. http://apps.who.int/medicinedocs/en/d/Js4893e/ (cited 1 Dec 2016).

3. Coscia LA, Armenti DP, King RW, Sifontis NM, Constantinescu S, Moritz MJ. Update on the teratogenicity of maternal Mycophenolate Mofetil. J Pediatr Genet. 2015;4(2):42–55.

4. Mittendorf R. Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero. Teratology. 1995;51(6):435–45.

5. World Health Organization. Potential safety issue affecting women living with HIV using dolutegravir ar the time of coenception. 2018. http://www.who.int/medicines/publications/drugalerts/Statement_on_DTG_18May_2018final.pdf (cited 13 Jun 2018).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System;Frontiers in Pharmacology;2022-11-10

2. Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity;Annals of Internal Medicine;2022-01

3. Pregnancy Loss Signal from Prostaglandin Eye Drop Use in Pregnancy: A Disproportionality Analysis Using Japanese and US Spontaneous Reporting Databases;Drugs - Real World Outcomes;2021-11-19

4. Comment on: "Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)";Drug Safety;2021-07-29

5. Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score Strategies;Drug Safety;2020-03-02